Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial

To assess the efficacy of gonadotropin-releasing hormone agonist (GnRHa) in preventing chemotherapy-induced ovarian failure in patients treated for Hodgkin or non-Hodgkin lymphoma within the setting of a multicenter, randomized, prospective trial. Patients age 18 to 45 years were randomly assigned t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2013-03, Vol.31 (7), p.903-909
Hauptverfasser:	DEMEESTERE, Isabelle, BRICE, Pauline, BRON, Dominique, ENGLERT, Yvon, PECCATORI, Fedro A, KENTOS, Alain, GAILLARD, Isabelle, ZACHEE, Pierre, CASASNOVAS, Rene-Olivier, VAN DEN NESTE, Eric, DECHENE, Julie, DE MAERTELAER, Vivianne
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Biomarkers - blood Drug Therapy, Combination Estradiol - blood Female Follicle Stimulating Hormone - blood Follow-Up Studies Gonadotropin-Releasing Hormone - agonists Hematologic and hematopoietic diseases Hodgkin Disease - drug therapy Humans Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Luteolytic Agents - therapeutic use Lymphoma - drug therapy Lymphoma, Non-Hodgkin - drug therapy Medical sciences Middle Aged Norethindrone - therapeutic use Premenopause Primary Ovarian Insufficiency - blood Primary Ovarian Insufficiency - chemically induced Primary Ovarian Insufficiency - prevention & control Prospective Studies Time Factors Treatment Failure Triptorelin Pamoate - therapeutic use Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!